Editorial Open Access
Nanotechnology in Dental Materials: Ready for Prime Time?
Jinghao Wang1,2,*, Cody Lam1, Yu-chi Cheng1,3,4
- 1Harvard School of Dental Medicine, Boston, MA, USA
- 2Vascular Biology Program, Boston Children’s Hospital, Boston, MA, USA
- 3Pathology Department, Brigham and Women’s Hospital, Boston, MA, USA
- 4Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA
Corresponding Author
Jinghao Wang, jinghao_wang@hsdm.harvard.edu
Received Date: October 13, 2026
Accepted Date: October 19, 2026
Wang J, Lam C, Cheng YC. Nanotechnology in Dental Materials: Ready for Prime Time? Arch Dent. 2026;8(1):27–30.
Copyright: © 2026 Wang J, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Dental Practice Covid-19 Infection Control Precautions
In the end of 2019, a large number of patients started suffering from a disease that includes symptoms which can be displayed as a severe pneumonia and acute respiratory distress syndrome, in addition to multi organ dysfunction. These symptoms were detected in Wuhan, which is considered the capital city of Hubei province, with
Ischemic Cardiomyopathy Evaluation with Coronary Calcium Score and CT Angiogram
Our study aimed to examine the prevalence of atherosclerotic burden in a predominantly non-white cohort of patients from LA County who underwent coronary artery calcium scoring (CACS) and coronary CT angiogram (CCTA) for the evaluation of cardiomyopathy of ischemic origin. Ischemic cardiomyopathy, primarily caused by reduced blood supply to the heart, is the most common type of cardiomyopathy.
Gut Microbiota Metabolite Trimethylamine N-oxide Reduced Pancreatic β Cell Calcium Transients and Function
Pancreatic β cell dysfunction is an important cause of type 2 diabetes (T2D). Previous studies show trimethylamine N-oxide (TMAO), a gut microbiota-related metabolite, promotes cardiovascular disease and insulin resistance. However, the effect and mechanism of TMAO at pathological concentrations on β cell function remain unknown. The recently published work demonstrates TMAO reduces pancreatic β cell function and glucose homeostasis.
Ryanodine Receptor-Mediated Calcium Dysregulation as a Therapeutic Target for Treatment of Depression and Anxiety: A Commentary
Major depressive disorder and anxiety disorders together represent one of the largest sources of disability worldwide, and both remain difficult to treat [1,2]. A substantial share of patients fails to respond to first-line antidepressants, and relapse after apparent remission is common [3,4]. Ketamine and esketamine, antagonists of N-Methyl-D-aspartate (NMDA) receptors, have shown that correcting glutamatergic and Ca2+ signaling abnormalities can produce rapid symptomatic improvement even in treatment-resistant cases, but their use is constrained by abuse liability, dissociative side effects, and the need for monitored administration [5,6].